Nanotechnology in Medical Applications: The Global Market

Jan 2012| HLC069B| BCC Publishing

Report Highlights

The global nanomedicine market reached $43.2 billion in 2010 and $50.1 billion in 2011. The market is expected to grow to $96.9 billion by 2016 at a compound annual growth rate (CAGR) of 14.1% between years 2011 and 2016.

SCOPE OF REPORT

This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry is discussed with profiles of the leading 60+ companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

ANALYST CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous reports on the nanomedicine marketplace as well as analyses of major therapeutic categories and the pharmaceutical regulatory environment.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price Member Price
Full Report: Nanotechnology in Medical Applications: The Global Market 187 $2,750 Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY4$250Free
Chapter- 3: OVERVIEW10$147Free
Chapter- 4: NANOMEDICINE59$868Free
Chapter- 5: MARKETS FOR NANOMEDICINE 15$221Free
Chapter- 6: THE NANOMEDICINE INDUSTRY92$1,353Free
Chapter- 7: APPENDIX4$59Free
Published - Jan-2010| Analyst - Paul Evers| Code - HLC069A

Report Highlights

  • The global nanomedicine market was valued at $53 billion in 2009, and is forecast to increase at a compound annual growth rate (CAGR) of 13.5% to reach more than $100 billion in 2014. 
  • Nanomedical products for cancer are one of the largets market segments, worth nearly $20 billion in 2009. This sector is expected to increase at a compound annual growth rate (CAGR) of 11% to reach $33 billion in 2014.
  • Nanomedicine for CNS indications is another major market sector, valued at nearly $11 billion in 2009 and expected to reach $18 billion by 2014, an 11.1% compound annual growth rate (CAGR).

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report